Home > Drug Search >
  • company_query: BioNTech
  •   > 
Drug Filter
Category:
chemistry (13) biology (26)
Status:
Approved (4) Phase Ⅲ (6) Phase Ⅱ (16) Phase Ⅰ (13)
Clinical Stage:
Pending (5) Active (27) Discontinued (3)
Bio-Type:
Gene therapy (3) Cell therapy (2) Vaccine (12) Recombinant enzyme (1) Recombinant polypeptide (1) Other recombinant protein (2) Whole antibody (3)
Indication:
Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (2) Breast cancer (3) Chronic obstructive pulmonary disease (COPD) (1) ischaemic heart disorder (1) Community-acquired pneumonia (CAP) (1) Cystic fibrosis (CF) (2) Bronchitis (1) Diabetic nephropathy (1) Endometrial cancer (1) Heart failure (1) Adult respiratory distress syndrome (ADRS) (1) Melanoma (4) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (2) Pancreatic cancer (1) Parkinson's disease (PD) (1) Peripheral arterial disease (PAD) (1) Measles (1) Prostate cancer (1) Pulmonary arterial hypertension (3) Rheumatoid arthritis (RA) (2) Solid tumours (2) Thrombocytopenia (1) Leber congenital amaurosis (1) Carotid stenosis (1) Head and neck cancer (1) Colorectal cancer (5) Ankylosing Spondylitis (AS) (1) Pulmonary sarcoidosis (1) Neuroblastoma (1) Systemic inflammatory response syndrome (SIRS) (1) Diagnostic agents (2) Hypertrophic cardiomyopathy (1) Cardiomyopathy (1) Glioblastoma (2) Mesothelioma (2) Dengue fever (1) Renal failure (1) Cervical dysplasia (1) Myocardia ischemia (1)
Country:
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top